Our Products


Cytoxaline in combination with 5-Fluorouracil and Folinic acid is indicated for:

• The adjuvant treatment of colon cancer stage III (Dukes’ Stage C) after complete resection of primary tumor,

• The treatment of metastatic colorectal cancer.




Cytoxaline 5mg/mL


Cytokar is indicated for:

• Ovarian carcinoma of epithelial origin,
• Small cell bronchial carcinoma,
• Squamous cell carcinoma of the upper aerodigestive tract.

Cytokar 10mg/mL


Cytocis is indicated for:

• Testicular cancers,                  • Ovarian cancers,
• Head and neck cancers,         • Esophageal cancer,
• Cervical cancer,                       • Endometrial cancers,
• Bladder cancer,                       • Squamous cell cancers.
Cisplatin is typically used in polychemotherapy in combination with other antineoplastic drugs.

Cytocis 1mg/mL


Cytobicine is indicated for:

• Breast carcinomas,
• Ovarian cancers,
• Malignant non-Hodgkin’s lymphoma, Hodgkin’s disease,
• Microcellular lung cancers,
• Soft tissue sarcomas,
• Cancer of the esophagus, stomach, pancreas, hepatocellular cancers,
• Squamous cell carcinoma of the ear, nose and throat sphere.

Cytobicine 2mg/mL


Cytodox is indicated for:

• Breast cancer,
• Sarcomas of bones and soft tissues,
• hodgkin’ disease, non-Hodgkin lymphoma,
• Solid tumors of the child,
• Lung cancer,
• Acute and chronic leukemias,
• Bladder, ovarian, stomach cancers.

Cytodox 2mg/mL


Cytoflu is indicated for:

• Advanced Digestive adenocarcinomas,
• Colorectal Cancers after resection adjuvant,
• Breast adenocarcinomas after locoregional treatment or during relapse,
• Ovarian adenocarcinomas,
• Squamous cell carcinomas of the upper aerodigestive tract and esophagus.

Cytoflu 50mg/mL


Cytogem  is indicated for:

• Non-small cell lung cancer (NSCLC), alone or together with cisplatin,
• Pancreatic cancer,
• Breast cancer, together with paclitaxel,
• Ovarian cancer, together with carboplatin,
• Bladder cancer, together with cisplatin.

Cytogem 40mg/mL


Cytopaxel is indicated for:

•  Ovarian carcinoma,
•  Breast carcinoma,
•  Advanced non-small cell lung carcinoma,
•  AIDS-related Kaposi’s sarcoma.

Cytopaxel 6mg/mL


Cytotere is indicated for:

• Breast Cancer,
• Localy advanced or metastatic NSCLC
• Prostate cancer,
• Upper aerodigestive tract cancer,
• Gastric cancer.

Cytotere 20mg/mL


Cytotecan is indicated for:

• Advanced colorectal cancers

Cytotecan 20mg/mL